This inventor holds 1 USPTO granted patent. Top assignee: Tap Pharmaceutical Products Inc.. Active years: 2003.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2003
Title: Debra Sutkowski-Markmann: Innovator in Apomorphine Derivatives
Introduction
Debra Sutkowski-Markmann is a notable inventor based in Willow Springs, IL (US). She has made significant contributions to the field of pharmaceuticals, particularly in the development of apomorphine derivatives. Her work focuses on enhancing the effectiveness of treatments for sexual dysfunction.
Latest Patents
Debra holds a patent for "Apomorphine derivatives and methods for their use." This patent includes apomorphine derivative compounds, pharmaceutically active compositions of these compounds, and their application in treating sexual dysfunction. The derivatives may take various forms, including esters, ethers, amides, mixed anhydrides, hemiacetals, glucuronates, sulfates, or phosphonates. A preferred derivative identified in her patent is norapomorphine. She has 1 patent to her name.
Career Highlights
Debra is currently associated with Tap Pharmaceutical Products Inc., where she continues to innovate in the pharmaceutical sector. Her work has the potential to significantly impact the treatment of sexual dysfunction, providing new avenues for patient care.
Collaborations
Throughout her career, Debra has collaborated with esteemed colleagues such as Pramod Gupta and Deborah Milkowski. These partnerships have likely contributed to her success and the advancement of her research.
Conclusion
Debra Sutkowski-Markmann is a pioneering inventor whose work on apomorphine derivatives showcases her commitment to improving pharmaceutical treatments. Her contributions are valuable to the field and highlight the importance of innovation in healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile